Dishman Carbogen Amcis' Q1 FY 2025-26 Quarterly Results

Result Summary

• Dishman Carbogen Amcis Ltd reported a 10.7% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 39.5%.
• Its expenses for the quarter were down by 2.3% QoQ and up 15.8% YoY.
• The net profit decreased 133.5% QoQ and decreased 130.2% YoY.
• The earnings per share (EPS) of Dishman Carbogen Amcis Ltd stood at 1.5 during Q1 FY 2025-26.

Financial Statments for Q1 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Dishman Carbogen Amcis Ltd operates in the pharmaceutical industry, primarily engaged in the development, manufacture, and supply of active pharmaceutical ingredients (APIs) and intermediates. The company serves a diverse clientele, including pharmaceutical companies, biotechnology firms, and specialty chemical companies. Dishman Carbogen Amcis Ltd is known for its expertise in the production of high-quality APIs and its strong capabilities in providing contract research and manufacturing services. Recent developments in the company could involve strategic partnerships or expansions in their service offerings, although specific events are not detailed here.

Revenue

In Q1FY26, Dishman Carbogen Amcis Ltd reported a total income of ₹732.80 crores, reflecting a quarter-over-quarter (QoQ) increase of 10.7% from the previous quarter, Q4FY25, where total income was ₹661.87 crores. On a year-over-year (YoY) basis, total income increased by 39.5% compared to Q1FY25 when the reported total income was ₹525.21 crores. This substantial YoY growth in revenue indicates an increase in the company's business activities compared to the same quarter in the previous year. The consistent growth in revenue over both the QoQ and YoY periods highlights strong business momentum during this quarter.

Profitability

The profitability of Dishman Carbogen Amcis Ltd showed significant improvement in Q1FY26. The company reported a profit before tax of ₹38.67 crores, a notable turnaround from the losses reported in both the previous quarter, Q4FY25, and the same quarter last year, Q1FY25. Specifically, Q4FY25 saw a loss before tax of ₹49.20 crores, while Q1FY25 recorded a loss before tax of ₹77.56 crores. The quarter-over-quarter change in profit before tax was -178.6%, and the year-over-year change was -149.9%. The profit after tax for Q1FY26 was ₹23.41 crores, contrasting with the losses of ₹69.92 crores in Q4FY25 and ₹77.57 crores in Q1FY25. Earnings per share (EPS) also improved significantly, moving from negative figures in previous quarters to ₹1.50 in Q1FY26.

Operating Metrics

Examining the operating metrics, Dishman Carbogen Amcis Ltd's total expenses for Q1FY26 were ₹691.48 crores, which represents a decrease of 2.3% from the previous quarter's expenses of ₹707.98 crores. Compared to Q1FY25, where expenses were ₹597.33 crores, there was a 15.8% increase in total expenses. The decrease in expenses QoQ, coupled with the increase in income, contributed to the improved profitability for the quarter. The tax expense for Q1FY26 was ₹15.26 crores, which decreased by 26.4% compared to the previous quarter. However, when compared to Q1FY25, the tax outlay increased substantially due to the company's return to profitability. The company's improved financial performance in Q1FY26 reflects a positive shift in its operational efficiencies and financial management.